Azulfidine EN-Tabs Uses
Rheumatoid ArthritisRheumatoid arthritis is an autoimmune disease. This means that, for some reason, the immune system mistakes a person's own cells as invaders and attacks them, causing damage. Similar to other autoimmune diseases, scientists still do not know the causes of rheumatoid arthritis.
There are many symptoms of rheumatoid arthritis, including chronic pain, along with tender, warm, and swollen joints. Azulfidine En-tabs is approved to treat the signs and symptoms of rheumatoid arthritis.
Juvenile Rheumatoid Arthritis
Juvenile rheumatoid arthritis is a form of rheumatoid arthritis that begins in childhood. With this condition, the immune system begins to attack the body (including the joints), causing pain. Other symptoms of juvenile rheumatoid arthritis include:
- Unexplained rashes
- Swollen joints
Azulfidine EN-tabs is approved to reduce the signs and symptoms of moderate to severe polyarticular juvenile rheumatoid arthritis. "Polyarticular" means that the arthritis affects five or more joints.
How Does the Medication Work?Azulfidine EN-tabs belongs to a group of medications called aminosalicylates. It is thought that it works by inhibiting the production of inflammatory chemicals in the lining of the colon. Azulfidine EN-tabs decreases the production of prostaglandins and leukotrienes, chemicals that lead to the inflammation caused by ulcerative colitis.
It is not fully understood how exactly the drug works to treat rheumatoid arthritis and juvenile rheumatoid arthritis. However, it is thought that it likely works by decreasing inflammation and also by affecting the immune system.